Impulse Dynamics unveils 100th implant milestone in China

KUALA LUMPUR, Nov 17 (Bernama) -- Impulse Dynamics, a global medical device company has announced the 100th implant in China, signifying the opportunity for its innovative Optimizer® system delivering CCM® therapy in markets around the world.

Cardiologist Prof. Guo Tao, Executive Director of Internal Medicine, Fuwai Cardiovascular Hospital, Yunnan Province, performed the 100th procedure and emphasised the role of this therapy in providing an option and hope to patients living with the debilitating reality of heart failure.

“We are proud to see the growing acceptance of this technology in markets around the world. In reaching this milestone, we have connected with physicians, patients, and their families,” said Impulse Dynamics’ Vice President International, Mateusz Zelewski, MD.

“We are inspired by the benefits of this therapy to our patients and continue to reinforce our commitment to address the immense need for advanced heart failure options for patients around the world.”

According to a statement, CCM therapy was approved in China late last year, and the first implant in the country was announced on Nov 1, 2021.

The Optimizer system delivers CCM therapy, which consists of electric pulses applied to the heart between heartbeats and serves to enhance the performance of cardiac muscular contraction, making the heart work more efficiently without increasing the heart rate or the oxygen consumption of the cardiac muscle.

To date, CCM therapy has been used to treat heart failure in more than 7,000 patients worldwide and is available in 44 countries across the globe.

More details at www.ImpulseDynamics.com.

-- BERNAMA